Is Apollo Hospitals overvalued or undervalued?

As of 24 October 2025, Apollo Hospitals' valuation grade has moved from fair to attractive, indicating a more favorable assessment of its value. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 71.66, an EV to EBITDA of 36.84, and a ROE of 17.61%.
In comparison to its peers, Apollo Hospitals stands out with a PEG ratio of 1.38, while Max Healthcare and Fortis Health have significantly higher PE ratios of 95.69 and 84.7, respectively. Despite a recent decline in stock price, Apollo Hospitals has outperformed the Sensex over the past year with a return of 12.42% compared to the Sensex's 5.18%. This performance reinforces the view that Apollo Hospitals is undervalued in the current market context.